Product Information
METHYLPHENIDATE ER 20 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.5131 per EA under NDC 70010004301. Its NADAC has been published 377 times since Jul 17, 2019.
FDA first approved this application on Nov 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010004301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210992FDA Approved
11/21/2018
TE Code
AB
On Market Since
12/17/2018
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 20 MG TAB has been published 377 times since Jul 17, 2019, and over the history we have for it it has declined 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5131 per EA |
|---|---|
| All-time high | $1.8065 (Aug 14, 2019) |
| All-time low | $0.3203 (Apr 17, 2024) |
| 52-week high | $0.5245 |
| 52-week low | $0.4885 |
| Median price | $0.5201 |
| Average price | $0.7223 |
| Largest weekly change | +56.4% (Sep 22, 2021) |
| Weeks tracked | 377 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 20 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.5131 per EA (NDC 70010004301), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE ER 20 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 20 MG TAB has declined 71.6%. It has been tracked across 377 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 20 MG TAB?
Since Jul 17, 2019, the NADAC for METHYLPHENIDATE ER 20 MG TAB has ranged from a low of $0.3203 (Apr 17, 2024) to a high of $1.8065 (Aug 14, 2019), with a median of $0.5201 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 20 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 20 MG TABLET, is $0.2014 per EA — about 61% below METHYLPHENIDATE ER 20 MG TAB.
Who manufactures METHYLPHENIDATE ER 20 MG TAB?
METHYLPHENIDATE ER 20 MG TAB (NDC 70010004301) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.